Editorial
doi: 10.1001/jamacardio.2021.1448.
Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?
Affiliations
- PMID: 34037664
- DOI: 10.1001/jamacardio.2021.1448
Item in Clipboard
Editorial
Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?
JAMA Cardiol.
.
No abstract available
Comment on
-
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.JAMA Cardiol. 2021 Aug 1;6(8):926-935. doi: 10.1001/jamacardio.2021.1437. JAMA Cardiol. 2021. PMID: 34037681 Free PMC article.
Similar articles
-
Is Dapagliflozin Cost-effective for Treating Heart Failure?JAMA. 2021 Aug 3;326(5):378. doi: 10.1001/jama.2021.12116. JAMA. 2021. PMID: 34342627 No abstract available.
-
Dapagliflozin (Farxiga) - a new indication for heart failure.Med Lett Drugs Ther. 2020 Jun 29;62(1601):102-103. Med Lett Drugs Ther. 2020. PMID: 32724023 No abstract available.
-
Dapagliflozin in patients with heart failure and reduced ejection fraction.Intern Emerg Med. 2020 Apr;15(3):515-517. doi: 10.1007/s11739-020-02297-0. Intern Emerg Med. 2020. PMID: 32124206 No abstract available.
-
Two Tales: One Story: EMPEROR-Reduced and DAPA-HF.Circulation. 2020 Dec 8;142(23):2201-2204. doi: 10.1161/CIRCULATIONAHA.120.051122. Epub 2020 Sep 24. Circulation. 2020. PMID: 32969716 Review. No abstract available.
-
Dapagliflozin: A Sodium Glucose Cotransporter 2 Inhibitor for the Treatment of Diabetes Mellitus.J Pharm Pract. 2016 Apr;29(2):165-71. doi: 10.1177/0897190014566308. Epub 2015 Jan 21. J Pharm Pract. 2016. PMID: 25609661 Review.
Cited by
-
Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.J Am Coll Cardiol. 2023 May 23;81(20):2043-2055. doi: 10.1016/j.jacc.2023.03.402. J Am Coll Cardiol. 2023. PMID: 37197848 Free PMC article. Review.
-
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure.J Am Heart Assoc. 2022 Jun 20;11(12):e023789. doi: 10.1161/JAHA.121.023789. Online ahead of print. J Am Heart Assoc. 2022. PMID: 35723002 Free PMC article.
-
Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.Circulation. 2022 Mar 15;145(11):819-828. doi: 10.1161/CIRCULATIONAHA.121.056276. Epub 2022 Jan 19. Circulation. 2022. PMID: 35044802 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
